Publicacións en colaboración con investigadores/as de Hospital Regional Universitario de Málaga (36)

2024

  1. Chronic Obstructive Lung Disease: Treatment Guidelines and Recommendations for Referral and Multidisciplinary Continuity of Care

    Journal of Clinical Medicine, Vol. 13, Núm. 2

  2. Reliability of blood eosinophil count in steady-state bronchiectasis

    Pulmonology

  3. Use of Triple Therapy in Asthma: The GEMAFORUM V Task Force

    Journal of investigational allergology & clinical immunology, Vol. 34, Núm. 4, pp. 257-260

2023

  1. Bronchiectasis: Changes in the Characterization of Patients During 20 Years of Follow-up. Data from the Spanish Bronchiectasis Registries

    Archivos de Bronconeumologia, Vol. 59, Núm. 10, pp. 688-690

  2. Clinical Practice Guideline of Spanish Society of Pneumology and Thoracic Surgery (SEPAR) on Pharmacological Treatment of Tobacco Dependence 2023

    Archivos de Bronconeumologia, Vol. 59, Núm. 10, pp. 651-661

  3. Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease

    Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 556-565

  4. Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology

    Reumatologia Clinica, Vol. 19, Núm. 2, pp. 74-81

  5. Telemedicine and severe asthma in our environment: Views on the experience of professionals and suggestions to make it a reality

    Open Respiratory Archives, Vol. 5, Núm. 3

  6. The U-Shaped Relationship Between Eosinophil Count and Bronchiectasis Severity: The Effect of Inhaled Corticosteroids

    Chest, Vol. 164, Núm. 3, pp. 606-613

2022

  1. Blood Neutrophil Counts Define Specific Clusters of Bronchiectasis Patients: A Hint to Differential Clinical Phenotypes

    Biomedicines, Vol. 10, Núm. 5

  2. EAACI position paper on the clinical use of the bronchial allergen challenge: Unmet needs and research priorities

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 6, pp. 1667-1684

  3. Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 11-21

  4. Impact of Chronic Bronchial Infection by Staphylococcus aureus on Bronchiectasis

    Journal of Clinical Medicine, Vol. 11, Núm. 14

  5. Peripheral Neutrophil-to-Lymphocyte Ratio in Bronchiectasis: A Marker of Disease Severity

    Biomolecules, Vol. 12, Núm. 10

  6. Real Life With Tezacaftor and Ivacaftor in Adult Patients With Cystic Fibrosis: Spanish Multicenter Study

    Archivos de Bronconeumologia, Vol. 58, Núm. 9, pp. 672-674

  7. SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis

    Reumatologia Clinica, Vol. 18, Núm. 8, pp. 443-452

  8. SER-SEPAR recommendations for the the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment

    Reumatologia Clinica, Vol. 18, Núm. 9, pp. 501-512

  9. Smoking, vaping, nicotine and the risk of cancer

    ERS Monograph, Vol. 2022, Núm. 98, pp. 59-70

  10. Systemic Inflammatory Biomarkers Define Specific Clusters in Patients with Bronchiectasis: A Large-Cohort Study

    Biomedicines, Vol. 10, Núm. 2

  11. [Translated article] Smoking Cessation Units as a Source of COPD Diagnoses: Project 1000-200

    Archivos de Bronconeumologia, Vol. 58, Núm. 3, pp. T264-T267